Wordt geladen...
Resibufogenin suppresses transforming growth factor‐β‐activated kinase 1‐mediated nuclear factor‐κB activity through protein kinase C‐dependent inhibition of glycogen synthase kinase 3
Resibufogenin (RB), one of the major active compounds of the traditional Chinese medicine Chansu, has received considerable attention for its potency in cancer therapy. However, the anticancer effects and the underlying mechanisms of RB on pancreatic cancer remain elusive. Here, we found that RB inh...
Bewaard in:
| Gepubliceerd in: | Cancer Sci |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6215888/ https://ncbi.nlm.nih.gov/pubmed/30168902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13788 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|